Northwestern Mutual Wealth Management
HUMA icon

Northwestern Mutual Wealth Management’s Humacyte HUMA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-172
Closed -$104 – 4267
2026
Q1 		$104 Hold
172
– – ﹤0.01% 3993
2025
Q4 		$165 Hold
172
– – ﹤0.01% 3820
2025
Q3 		$299 Hold
172
– – ﹤0.01% 3678
2025
Q2 		$359 Buy
+172
New +$330 ﹤0.01% 3471
2025
Q1 		– Sell
-141
Closed -$712 – 3796
2024
Q4 		$712 Buy
+141
New +$698 ﹤0.01% 3344

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northwestern Mutual Wealth Management's HUMA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 172 shares — an estimated $104 sold.

Northwestern Mutual Wealth Management first reported a position in HUMA in Q4 2024 and held it in 5 quarters. The position peaked at $712 in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 172 Humacyte shares in Q2 2026, an estimated $104.
  • Northwestern Mutual Wealth Management first reported a position in Humacyte in Q4 2024 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Humacyte position peaked at $712 in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.